A Triumph Of Classical Physics: How The Negative Pressure Suction Mechanism Of Menghini Needles Defines The Gold Standard Safety Margin For Liver Biopsy

A Triumph of Classical Physics: How the Negative Pressure Suction Mechanism of Menghini Needles Defines the Gold Standard Safety Margin for Liver Biopsy

Keywords:​ Negative pressure suction Menghini liver biopsy needle + Achieving rapid, low-trauma columnar liver tissue acquisition

In the diagnostic temple of liver pathology, a seemingly simple puncture needle has defended its status as the "gold standard" for tissue sampling for over half a century, thanks to its unique physics principles. Invented by Giorgio Menghini in 1958, the revolutionary nature of the Menghini needle does not stem from expensive materials or complex structures, but rather from its exquisite combination of the basic physical concept of "negative pressure suction" with the physiological and anatomical characteristics of the blood-rich liver organ. This establishes a difficult-to-surpass balance between the two fundamentally conflicting goals of "obtaining sufficient diagnostic samples" and "minimizing the risk of bleeding."

Synergy of "Suction" and "Cutting": Deconstructing the Menghini Mechanism

Unlike Tru-Cut needles that rely on mechanical cutting to obtain tissue, the essence of the Menghini needle lies in "replacing cutting with suction, and suction preceding separation." The standard operating procedure is as follows: under ultrasound guidance, a thin-walled cannula needle (typically 16–18G) with a sharp bevel is rapidly inserted to a position beneath the liver capsule. The critical step follows: the operator stabilizes the needle with one hand while vigorously withdrawing the plunger of a pre-attached syringe with the other, locking it in place to maintain maximum negative pressure. At this point, local liver tissue at the needle tip is "sucked" into the needle lumen under a high negative pressure of up to 500–600 mmHg. Subsequently, the operator swiftly yet steadily advances the needle into the liver tissue by about 2–4 cm and immediately withdraws it, completing the entire process within 1–2 seconds. During needle withdrawal, the separation of the sucked-in liver tissue strip from the surrounding organs relies less on the cutting action of the needle blade, and more on the "adsorption fixation" effect generated by tissue elasticity recoil and sustained negative pressure in the syringe. This brings two core advantages: 1) The sample is intact and columnar, typically 1.5–3.0 cm long, preserving the integrity of the hepatic lobule structure-particularly beneficial for assessing fibrosis staging (e.g., METAVIR scoring); 2) Mechanical shear force on blood vessels and bile ducts is significantly reduced because the needle body exits while "holding" the tissue via suction, rather than "cutting through" the tissue, theoretically minimizing the risk of tearing small portal vein branches.

The "Safety Design" Philosophy for High-Risk Cirrhotic Patients

The most dangerous complication of liver biopsy is bleeding, especially in patients with existing cirrhosis and portal hypertension. The "high-speed puncture, instantaneous sampling" characteristic of the Menghini needle makes its safety profile particularly prominent in this population. The initial trauma channel created by the thin-walled needle tube during puncture is extremely small. More importantly, the moment tissue is sucked into the lumen, the high negative pressure inside the needle theoretically exerts an "adsorptive closure" effect on surrounding microvessels. After sampling is complete, due to the slender needle tract and the elasticity of the liver parenchyma, the tract collapses and seals rapidly. Combined with postoperative positional compression (right lateral decubitus position), this effectively utilizes the liver's own pressure to achieve hemostasis. Extensive clinical evidence indicates that in the hands of experienced operators, the incidence of severe bleeding (requiring transfusion or intervention) using the Menghini needle for percutaneous liver biopsy can be controlled to below 0.1%-a safety record fundamental to its enduring legacy.

Optimization of "One-Shot" Operation and Tissue Preservation

Menghini needle systems are typically designed as a one-piece disposable unit, or feature a tight connection between the needle tube and a dedicated large-capacity (usually 10–20 ml) syringe. This "integrated" design avoids component assembly or sample transfer during tense procedures, achieving a seamless workflow of "puncture-aspiration-withdrawal-sample acquisition." This not only improves efficiency but also reduces the risk of sample exposure to air or artificial crush injury. The retrieved intact liver tissue strip is gently blown into fixative solution (e.g., formalin); its intact columnar morphology provides the optimal basis for histopathology sectioning, ensuring serial sections can be made to comprehensively evaluate hepatitis activity, fibrosis degree, and iron/copper deposition.

Adaptive Evolution Under Modern Image Guidance

Although the Menghini needle was born in an era before widespread ultrasound guidance, its integration with modern imaging technology is near perfect. Under real-time ultrasound guidance, operators can precisely select the needle path to avoid large intrahepatic vessels, the gallbladder, and the lungs. For focal lesion biopsies, the modern modified "coaxial technique" is often combined with the Menghini principle: a slightly thicker guiding sheath is first implanted at the lesion edge, through which a finer Menghini needle is passed for multiple negative pressure aspirations. This allows for obtaining multiple tissue strips without repeatedly puncturing the liver capsule, greatly improving the diagnostic positive rate for small hepatocellular carcinomas or difficult lesions, while further dispersing the risk of complications.

The success of the Menghini needle stands as a medical paradigm of engineering wisdom that simplifies complexity. It relies not on complex mechanical moving parts, but on the ultimate application of basic physical principles to perfectly unify operational risk and diagnostic efficacy. Amidst the endless emergence of various new biopsy devices today, the Menghini needle and the negative pressure suction principle it represents remain the "benchmark" against which any new liver biopsy technology is evaluated. Its core values of simplicity, speed, and safety continue to provide the most reliable diagnostic cornerstone for millions of liver disease patients worldwide.